{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "28746057", "DateCompleted": {"Year": "2017", "Month": "12", "Day": "04"}, "DateRevised": {"Year": "2019", "Month": "12", "Day": "10"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.1097/CAD.0000000000000539"], "Journal": {"ISSN": "1473-5741", "JournalIssue": {"Volume": "28", "Issue": "9", "PubDate": {"Year": "2017", "Month": "Oct"}}, "Title": "Anti-cancer drugs", "ISOAbbreviation": "Anticancer Drugs"}, "ArticleTitle": "Solid lipid nanoparticles improve octyl gallate antimetastatic activity and ameliorate its renal and hepatic toxic effects.", "Pagination": {"StartPage": "977", "EndPage": "988", "MedlinePgn": "977-988"}, "Abstract": {"AbstractText": ["Metastasis is the main cause of cancer-related death and requires the development of effective treatments with reduced toxicity and effective anticancer activity. Gallic acid derivatives have shown significant biological properties including antitumoral activity as shown in a previous study with octyl gallate (G8) in vitro. Thus, the aim of this work was to evaluate the antimetastatic effect of free and solid lipid nanoparticle-loaded G8 in mice in a lung metastasis model. Animals inoculated with melanoma cells presented metastasis in lungs, which was significantly inhibited by treatment with G8 and solid lipid nanoparticle-loaded G8, named G8-NVM. However, G8-treated mice showed an increase in several toxicological parameters, which were almost completely circumvented by G8-NVM treatment. This study supports the need for pharmacological studies on new potential medicinal plants to treat cancer and can provide new perspectives on using nanotechnology to improve biological activities while decreasing the chemotherapy toxicological effects of anticancer drugs."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "aDepartment of Pharmaceutical Sciences bDepartment of Biochemistry cDepartment of Chemistry, Federal University of Santa Catarina dNanovetores Technology S.A., Florian\u00f3polis eUniversity of Western Santa Catarina, Videira, SC fFederal University of Tocantins, Aragua\u00edna, TO, Brazil."}], "LastName": "Cordova", "ForeName": "Clarissa A S", "Initials": "CAS"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Locatelli", "ForeName": "Claudriana", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Winter", "ForeName": "Evelyn", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Silva", "ForeName": "Adny H", "Initials": "AH"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Zanetti-Ramos", "ForeName": "Betina G", "Initials": "BG"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Jasper", "ForeName": "Raquel", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Mascarello", "ForeName": "Alessandra", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Yunes", "ForeName": "Rosendo A", "Initials": "RA"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Nunes", "ForeName": "Ricardo J", "Initials": "RJ"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Creczynski-Pasa", "ForeName": "T\u00e2nia B", "Initials": "TB"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Anticancer Drugs", "NlmUniqueID": "9100823", "ISSNLinking": "0959-4973"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Lipids"}, {"RegistryNumber": "0", "NameOfSubstance": "Reactive Oxygen Species"}, {"RegistryNumber": "079IIA2811", "NameOfSubstance": "octyl gallate"}, {"RegistryNumber": "632XD903SP", "NameOfSubstance": "Gallic Acid"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["etiology", "prevention & control"], "DescriptorName": "Chemical and Drug Induced Liver Injury"}, {"QualifierName": [], "DescriptorName": "Chlorocebus aethiops"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["administration & dosage", "adverse effects", "analogs & derivatives", "chemistry"], "DescriptorName": "Gallic Acid"}, {"QualifierName": ["chemically induced", "prevention & control"], "DescriptorName": "Kidney Diseases"}, {"QualifierName": ["administration & dosage", "chemistry"], "DescriptorName": "Lipids"}, {"QualifierName": ["drug therapy", "metabolism", "secondary"], "DescriptorName": "Lung Neoplasms"}, {"QualifierName": ["drug therapy", "metabolism", "pathology"], "DescriptorName": "Melanoma, Experimental"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["administration & dosage", "chemistry"], "DescriptorName": "Nanoparticles"}, {"QualifierName": [], "DescriptorName": "Neoplasm Metastasis"}, {"QualifierName": ["metabolism"], "DescriptorName": "Reactive Oxygen Species"}, {"QualifierName": [], "DescriptorName": "Vero Cells"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2017", "Month": "7", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "12", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "7", "Day": "27", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["28746057", "10.1097/CAD.0000000000000539"]}}]}